Myeloma Other
Bleeding complications of targeted oral anticoagulants: What is the risk?
靶向口服抗凝剂的出血并发症：风险如何？
The targeted oral anticoagulants: Practical considerations
靶向口服抗凝剂：实践中的思考
Reversal of the new oral anticoagulants
新型口服抗凝剂的逆转效应
Anticoagulation: In vitro fertilization and ovarian stimulation
体外受精和卵巢刺激过程中的抗凝问题
Pregnancy and venous thromboembolism (VTE): “TIPPS” for risk stratification
妊娠与静脉血栓栓塞（VTE）：TIPPS风险分级
Anticoagulation in pregnancy complications
妊娠合并症与抗凝治疗
New insights into treatment of venous thromboembolism
静脉血栓栓塞的治疗新进展
Keeping the pipes open: Management of catheter-associated thrombosis
保持管路通畅：如何处理导管相关血栓
Prevention and treatment of venous thromboembolism in patients with cancer
肿瘤患者静脉血栓栓塞的预防和处置
Recent insights into the role of the contact pathway in thrombo-inflammatory disorders
接触通路在血栓炎症性疾病中作用的最新见解
Epidemiologic and clinical data linking factors XI and XII to thrombosis
Ⅺ因子和Ⅻ因子与血栓形成之间的流行病学和临床数据
Future prospects for contact factors as therapeutic targets
接触因子作为治疗靶点的未来前景
Update in congenital platelet syndromes
先天性血小板综合征的最新报道
Pharmacogenomics of antiplatelet drugs
抗血小板药物的药物基因组学
Management of MPN beyond JAK2
基于JAK2基因突变进行骨髓增殖性肿瘤的处理
Platelets: More than a sack of glue
血小板：不仅仅是一袋胶
RBCs as targets of infection
作为感染靶标的RBCs
Flamethrowers: Blood cells and cancer thrombosis risk
血液细胞和癌症血栓形成的风险
